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Summary
Objective: To evaluate the efficacy of a program of lifestyle change through psychological intervention, combined 
with pharmacological therapy, for coronary risk reduction in uncontrolled hypertensive patients with overweight and 
dyslipidemia over 11 months of follow-up. 
Methods: A randomized controlled trial with 74 patients assigned to three different treatment programs. One group (CT) 
only received conventional pharmacological treatment. Another group (OG) received pharmacological treatment and 
participated in a guidance program to control cardiovascular risk factors. A third group (LSPI) received pharmacological 
treatment and participated in a brief psychological intervention program for reduction of stress levels and changing of 
eating behavior. The main measure was the Framingham risk index.
Results: CT patients presented an average reduction of 18% (p = 0.001) in coronary risk; OG patients elevated the risk 
by 0.8% (NS) and the LSPI group showed an average reduction of 27% on the Framingham risk index (p = 0.001).  
Conclusion: Pharmacological treatment combined with psychological intervention for reduction of stress level and 
changing of eating behavior resulted in additional benefits in coronary risk reduction. (Arq Bras Cardiol 2007;88(6):624-
628)
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Introduction
Cardiovascular diseases are the leading cause of death in 
developed and developing countries1,2. Previous studies have 
shown that the joint approach of treatment with medication 
and a program of multiple risk factor intervention through 
educational guidance3,4 or behavioral intervention5,6,7 may 
promote additional benefits on cardiovascular morbidity and 
mortality rate reduction, compared with pharmacological 
treatment alone.
This study evaluates the effect of a program of lifestyle 
change through psychological intervention combined with 
pharmacological therapy for stress reduction and eating 
behavior change compared to pharmacological treatment 
alone and a guidance program for coronary risk reduction 
in uncontrolled hypertensive patients with overweight and 
dyslipidemia who underwent treatment for 11months.
Methods
Study design - The study was a randomized trial designed 
to compare the effects of a lifestyle psychological intervention 
(LSPI) for stress reduction and eating behavior change 
combined with pharmacological therapy with a conventional 
intervention for coronary risk reduction lasting 11 months. The 
42-week study was conducted at an outpatient hypertension 
clinic and divided into an 18-week intervention phase and a 
24-week result consolidation phase. The team consisted of 
four physicians, one psychologist and two psychology students. 
The study protocol was approved by the ethics committee of 
the Federal University of São Paulo, School of Medicine.
Sample - Inclusion criteria were: 1) hypertensive patients 
under antihypertensive medication who presented mean 
diastolic blood pressure (DBP) between 90 and 109 mmHg 
or systolic blood pressure (SBP) between 140 and 179 
mmHg in two  screening visits taken two months apart and 
conducted by the same physician; 2) both genders, age 35 
to 63 years; 3) body mass index (BMI) 25 to 34.9 kg/m2; 4) 
LDL-cholesterol ≥ 130 mg/dL, and HDL-cholesterol ≤ 40 
mg/dL.  Exclusion criteria were patients with history or ECG 
evidence of myocardial infarction, stroke, peripheral arterial 
obstruction, kidney failure, diabetes (fasting glucose ≥ 126 
mg/dL), and BMI over 35 kg/m2. Also excluded were patients 
who scored 7 or higher on the scale for psychiatric disturbance 
screening8,9 Self-Report Questionnaire 20 (SRQ 20), were 
intellectually impaired, had a history or current diagnosis of 
psychosis, or were alcohol (serum gamma-glutamyl transferase 
activity was assessed as a marker of alcohol consumption) or 
drug addicts. 
Consent was obtained from every patient after oral and 
written information was given. A centralized computer 
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the patients received information during 18 weekly 60-
minute sessions. A maximum of 10 participants was allowed 
per session. Information on hypertension, adherence to 
pharmacological treatment and coronary disease, cholesterol, 
alcohol consumption limits, smoking, salt restrictions, stress 
control, weight control and sedentary lifestyle were included 
in the program. In the result consolidation phase the same 
information was emphasized during 60-minute sessions held 
once a month over six months. 
Lifestyle psychological intervention group (n=24) - In 
addition to conventional treatment, all patients participated 
in a brief dynamic psychological intervention (Hobbs 1996, 
Sifneos 1989), planned in advance and conducted by the 
same psychologist. The goals were: 1) to provide the same 
information given to the OG group; 2) to increase adhesion 
to antihypertensive treatment, to reduce stress levels, weight 
loss of at least 5% of BMI (Hutton et al 2004), and walk at 
least three times a week for 30 minutes; 3) to identify and 
approach psychological conflicts involved in the difficulties of 
changing lifestyles and reaching the goals above.
The intervention phase took place during 18 eighteen 60-
minute meetings held once a week as with the OG. Three 
groups of eight patients were formed. Based on the group 
work, common stress generation factors were identified so 
as to provide proper guidance. Psychological issues involved 
in excessive food intake and sedentary lifestyle were likewise 
addressed. Each patient committed to goals of stress and 
weight reduction and physical activity increase.
The result consolidation phase followed, and consisted of 
60-minute group meetings held once a month. The objectives 
were to maintain the newly acquired behavior patterns and to 
reach unachieved goals. Notes were taken after each session 
for later analysis. 
Statistical methods - All data were analyzed according to 
the intention-to-treat principle. We used all available data. For 
baseline comparisons we used analysis of variance, repeated-
measures analysis of variance and Chi-square, whether the 
data had normal distribution or not. For within-group analyses, 
paired t-test, repeated- measures analysis of variance or when 
data had uneven distribution, the Wilcoxon signed rank and 
Fisher tests were used.
We used the Pearson correlation coefficient for each group 
to compare initial and final differences of the Framingham risk 
index, DBP and SBP, and HDL and LDL–cholesterol values. 
The chi-square test was used to test associations between 
increased HDL-C levels and simvastatin, physical activity and 
weight loss.  
Only p values < 0.05 were considered  statistically 
significant .
Results
The study sample comprised 74 patients, 5% of whom were 
smokers. Mean SBP and DBP were 148mmHg and 94mmHg, 
taken during screening visits. 
Six patients dropped out of the study during the first month 
of treatment (five in the CT and one in the OG). The statistical 
loss was irrelevant (p = 0.729) as 92% completed the study 
program randomly distributed patients into three groups: the 
conventional treatment group (CT, n= 21), orientation group 
(OG, n = 29), and lifestyle psychological intervention group 
(LSPI, n = 24).
Patients were duly informed that they could not miss 
more than three visits throughout the study, whether medical 
consultations or group interventions.
Eligibility for participation in the study was evaluated 
in hypertensive patients belonging to a cohort that was a 
representative sample of the clinic population. 
The psychological intervention and the orientation program 
were developed by a therapist other than the one who 
evaluated the patients. Both were documented in manuals 
for reference during the study. Study sample was  formed 
as follows: 82% of the patients were women and 38% were 
white; mean age was 50 (8.5) years; mean systolic and 
diastolic blood pressures were 136 (15) and 87 (11) mmHg, 
respectively (as documented by ambulatory blood pressure 
monitoring – ABPM); mean BMI 28.4 (3.4) kg/m2; mean 
LDL-C 138.6 (29.6) mg/dL; mean HDL-C 42.3 (10.5), 55% 
suffered from stress, 80% were considered physically inactive, 
and 5% were smokers.
Evaluation methods and procedures - The following 
parameters were measured at baseline and between weeks 
18 and 42: serum total cholesterol, high-density lipoprotein 
cholesterol and triglyceride concentrations (evaluated by 
enzymatic technique), low-density lipoprotein cholesterol 
(according to Friedewald’s formula), body mass index (BMI - 
kg/m2), creatinine (colorimetric evaluation), ambulatory  blood 
pressure monitoring (ABPM- Spacelabs, model 90207, Ecafix), 
glucose test (venous blood was drawn after an overnight fast) 
and ECG.
The following parameters were evaluated at baseline and on 
week 42:  Framingham risk index for each individual (Wilson 
et al 1998); adherence to antihypertensive medication through 
an anonymous questionnaire (patients were considered 
adherent if they reported taking their medication at least five 
days a week); physical activity (those who responded a brief 
questionnaire as practicing three times a week for at least 30 
minutes were considered physically active); Stress Symptom 
Inventory (SSI) (Lipp et al 1994), and smoking habits (examined 
with a brief questionnaire who considered any cigarette 
smoked during the last month). 
Patients with LDL-C ≥ 160mg/dL received a simvastatin 
prescription.
Conventional treatment (n=21) - All patients were 
monitored in the conventional manner by the same doctor 
every two to three months. For all groups the aim was 
to reduce systolic and diastolic blood pressures to levels 
below 140 and 90 mmHg, respectively. Overweight or 
hypercholesterolemic patients were treated according to the 
normal clinical practice. 
Orientation group (n=29) - In addition to conventional 
treatment, patients participated in a Guidance Program 
conducted by a psychologist. This program was developed 
to inform patients about cardiovascular risk factors and 
their associations with coronary disease and to stimulate 
lifestyle changes in two phases. In the intervention phase 
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with no more than three absences. 
Sample demographic characteristics at study entry are 
shown in Table 1. There were no significant differences among 
the three groups at baseline (Tables 1, 2 and 3), except for 
triglyceride values, higher in the CT group, and for the greater 
number of sedentary patients in the LSPI group. Blood pressure 
values in the Table 2 were obtained by ambulatory blood 
pressure monitoring (ABPM). 
The CT did not achieve SBP and DBP below 140 
and 90 mmHg, respectively (Table 2).  CT adherence to 
antihypertensive medication as informed by the patients 
remained constant at 21%. Within-group analyses revealed 
reductions in total cholesterol levels of 6% and LDL–cholesterol 
of 12%, in addition to an increase in HDL–cholesterol of 13% 
(Table 2). Simvastatin was prescribed for two patients (10%) at 
baseline and seven patients (33%) at the end of the study (p = 
0.017). The two smokers continued their habit throughout the 
study period. The CT group presented a significant reduction 
of 18% on the Framingham risk index (p = 0.001) (Table 3), 
and 50% of the patients were able to reduce the coronary 
risk (Figure 1). 
The OG group did not achieve SBP and DBP below 140 and 
90 mmHg, respectively (Table 2). Within-group comparisons 
(Table 2) showed that the indices of antihypertensive 
medication adherence rose from 18% to 24% (p < 0.001). 
There was a tendency for HDL–cholesterol to rise (p = 
0.066). Simvastatin was prescribed for two patients (6%) at 
baseline and four patients (13%) at the end of the study (NS). 
A significant reduction was found in the number of physically 
inactive patients: 20 patients in the beginning and 12 (p = 
0.008) at the end. The two smokers continued their habit 
during the entire study period. Thus, the OG group did not 
achieve a significant reduction in the Framingham risk index 
(Table 3).
The LSPI group did achieve SBP and DBP below 140 and 
90 mmHg, respectively, but only DBP dropped significantly 
(p = 0.026) (Table 2). Within-group analyses (Table 2) showed 
that indices of antihypertensive medication adherence rose 
from the initial 34% to 55% at the end of the study (p = 0.002). 
Total serum cholesterol concentrations dropped 5% as did 
LDL–cholesterol (11.6%), while HDL–cholesterol rose 10%. 
Simvastatin was prescribed for two patients (10%) initially and 
for three (13%) by the end of the study (NS). Body mass index 
(BMI) was reduced by 5% or more in 50% of the patients, and 
75% had become physically active (Table 2). We observed 
an expressive reduction on the mean percentage obtained 
in the ISS test (Table 2). LSPI presented a 27% decrease of 
Framingham risk index (p= 0.001) (Table 3) and 75% of the 
patients had their coronary risk reduced (Figure 1).
From the psychological standpoint, the following aspects 
were recurrent in all groups: denying hypertension (“why 
take any medication if I don’t feel anything?”, “my blood 
pressure is already under control and medication is no longer 
necessary”); denying excessive food intake (“my purpose is 
not gaining weight when I eat”, when patients are evidently 
overweight or obese); aspects related to voracity (eating until 
there’s an uncomfortable sense of fullness, eating in a hurry 
to have a second helping); denying obesity (“I’m not obese, 
Table 1 – Distribution of demographic characteristics
Characteristics CT (n= 21) OG (n= 29) LSPI (n = 24) p
Gender (%)
Female 15 ( 71) 27 (93) 19 (80) 0.122
Male 6 (29) 2 (7) 5 (20)
Ethnic group (%)
White 9 (43%) 12 (41) 7 (30)
Black/mixed race 12 (57%) 17 (59) 17 (70) 0.564
Age  (mean ± DP) 48 ± 9.8 50 ± 8.19 53 ± 8 0.143
Fig. 1 - Relative differences in the Framingham risk index.
CT OG LSPI
* Mean percentage reduction  – 18% (p=0.001)
# Mean percentage reduction  – 27% (p=0.001)
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I’m just slightly overweight”); denying consequences of obesity 
(“thin people are also going to die, so I’d rather die as a fat 
person”); denying coronary risk (“I  feel you are overstating 
my risk of heart attack”, “if I have a heart attack, I’m sure I’ll 
recover quickly”).
As far as stress control is concerned, the following behavior 
was noted: anxiety and hastiness when performing tasks; 
strictness when reviewing deadlines and priorities, tendency 
for over-accumulating tasks and responsibilities, and tendency 
to over- or underestimate the ability to solve problems.
Pearson correlation among relative differences observed 
both in HDL–cholesterol and coronary risk was – 0.61(p 
= 0.003) for CT, – 0.46 (p = 0.01) for OG and – 0.62 (p= 
0.001) for LSPI. Rises in HDL–cholesterol were related to the 
introduction or increase of simvastatin dosage (p = 0.017) in 
the CT, to physical activity increase (p = 0.016) in the OG 
and to weight loss (p < 0.001) in the LSPI.
Table 2 – Cardiovascular risk factors at baseline and after 18 and 42 weeks
TO T18 T42 p T0vsT42
SBP CT (n = 21) 140 ± 16.0 138 ± 14.4 142 ± 14.7 0.67
(ABPM) OG   (n = 29) 136 ± 18.7 135 ± 19.5 140 ± 18.6 0.456
LSPI (n=24) 132 ± 11.3 130 ± 12.9 127 ± 13.8 0.062
DBP CT 90 ± 11.1 88 ± 9.0 91 ± 7.6 0.927
(ABPM) OG 88 ± 13.0 88 ± 13.9 91 ± 13.4 0.58
LSPI 84 ± 8.2 84 ± 8.6 80.5 ± 8.8 0.026
Total Cholesterol (mg/dL) CT 204 ± 34 195 ± 22 192 ± 35 0.014
OG 205 ± 32 208 ± 46 204 ± 38 0.868
LSPI 217 ± 42 208 ± 40 206 ± 30 0.024
HDL–C (mg/dL) CT 38 ± 8.9 43 ± 14 44 ± 12.9 0.004
OG 43 ± 11.5 48 ± 12.8 51 ± 17 0.066
LSPI 46 ± 11.2 51 ± 10.7 57 ± 13 < 0.001
LDL–C(mg/dL) CT 133 ± 25 121 ± 21.5 117 ± 36.3 0.003
OG 136 ± 30 130 ± 32 125 ± 33.7 0.203
LSPI 147 ± 34 132 ± 33.4 130 ± 31.6 <0.001
Triglycerides (mg/dL) CT 171 ± 109.4 154 ± 89.3 148 ±85.6 0.069
OG 137 ± 64.4 145 ± 88 139 ±64.8 0.928
LSPI 120 ± 80 123 ± 55 116 ±41 0.368
Fasting Glucose (mg/dL) CT 91 ± 8.1 99 ± 21.2 89 ±8.2 0.433
OG 95 ± 12.0 96 ± 10.1 94 ±15.7 0.654
LSPI 91 ±14.3 91 ± 11.4 91 ±12.7 0.916
Body Mass Index (kg/m2) CT 27.8 ± 3.5 27.3 ± 2.7 27.3± 2.7 0.706
OG 28.4 ± 3.7 28 ± 3.8 28.2 ± 3.8 0.557
LSPI 29.0 ± 3.0 27.8 ± 2.8 27.4 ± 2.8 <0.001
Waist / Hip (cm) CT 0.91± 0.06 0.89 ±0.06 0.332
OG 0.88 ± 0.06 0.88 ± 0.05 0.722
LSPI 0.90 ± 0.06 0.86 ±  0.06 0.013
Stress  [% on SSI Test] CT 15.9 ± 22.9 13.5 ± 21.1 0.54
OG 21.3 ± 26.5 17.5 ± 25.4 0.625
LSPI 18.4 ± 23.2 6.6 ± 12.5 0.003
Sedentary Lifestyle (n) CT 14 13 0.187
OG 20 12 0.008
LSPI 24 6 <0.001
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Discussion
The patients in the Conventional Treatment group achieved 
an average reduction of 18% on the Framingham risk index. 
This was correlated to an increase in HDL cholesterol that 
was associated to the introduction or increase in simvastatin 
dosage. The importance of low levels of HDL cholesterol as a 
cardiovascular risk factor was reported in the studies of Planas 
et al (1980) and Orso et al (1982). Although this therapeutic 
approach may be effective, associate treatment costs are high 
and drug side effect risks are increased (Pezzilli et al 2004).
Patients require guidance to change their life habits and 
increase their adherence to treatment. In the orientation 
group, however, guidance was unable to change behavior 
that could reduce the Framingham risk factors. Other studies 
with a similar methodology and a one-year follow-up have 
presented controversial results (Ebrahim et al 2000). Other 
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results (Ebrahim et al 2000).
Although the final percentage of sedentary individuals in 
the orientation group was high (43%), the increase in physical 
activity was associated to the increase in HDL–C. This finding 
is compatible with the results of the meta-analysis conducted 
by Thompson et al., in 2003.
The patients in the lifestyle psychological intervention group 
showed an average reduction of 27% on the Framingham 
risk index, and 75% of patients showed a reduction in risk. 
This coronary risk reduction was correlated to an increase in 
HDL–C, obtained by changes in lifestyle as it was associated to 
weight loss.  Ginsberg et al. (2000) pointed out this effect. Ten 
percent of the patients went from overweight to normal-weight 
(≤ 24.9 kg/m2), and 20% of the patients initially considered 
as obese (IMC ≥ 30 kg/m2) ended the study with a body mass 
index classified as overweight (25 to 29,9Kg/m2).
 Conventional treatment alone seems to have been useful 
to patients with a profile of adherence to the pharmacological 
treatment, while medical treatment associated with 
psychological lifestyle intervention was useful for hypertensive 
patients with two or more cardiovascular risk factors, such as 
overweight/obesity and hyperlipidemia, as this strategy was 
capable of changing a greater number of risk factors, reducing 
exposure to medication side effects.
The psychological factors that may have contributed are: 
reduced anxiety in the entire group; addressing the relationship 
between stress and increasing food intake; identification of 
voracious eating; addressing maniac defenses such as denying 
reality, and considering oneself immune to consequences 
arising from this condition. This was observed as denial of 
hypertension, excessive food intake and obesity.
This study suggests that patients with abovementioned 
psychological characteristics need not only a medical approach, 
but also an emotional approach, as these characteristics may 
constitute an obstacle to successful treatment. 
New studies along this line of investigation may lead to 
enhanced therapeutic strategies for the different patient 
subgroups that present moderate to high coronary risks.
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Table 3 – Ten-year risk of coronary event
Treatment Baseline After 42 weeks Pvalue
Mean (%) Comparative mean Reduction (%)
CT 9.95 18 0.001
OG 7.65 — NS
LSPI 9.25 27 0.001
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